Related Experiment Videos

Two mechanisms of adriamycin-DNA interaction in L1210 cells

Biochemical Pharmacology
|October 15, 1984
PubMed

Insights

Adriamycin (ADR) can cause DNA damage through free radicals at high concentrations, leading to direct DNA single-strand breaks (D-SSB). However, at clinically relevant levels, ADR-DNA interactions do not appear to involve free radicals.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Background:

  • Adriamycin (ADR) is a potent chemotherapeutic agent whose cytotoxicity is linked to DNA interactions.
  • ADR induces two types of DNA damage: protein-associated DNA single-strand breaks (PA-SSB) and direct DNA single-strand breaks (D-SSB).

Purpose of the Study:

  • To investigate the role of free radicals in ADR-induced DNA damage.
  • To differentiate the mechanisms underlying PA-SSB and D-SSB formation at various ADR concentrations.

Main Methods:

  • Mouse leukemia L1210 cells were treated with ADR at concentrations of 2.8 X 10(-6) M, 10(-5) M, and 10(-4) M.
  • Cells were co-treated with antioxidant agents, including superoxide dismutase, catalase, dimethyl sulfoxide, ethanol, and 2-deoxy-glucose.
  • The frequency of D-SSB and PA-SSB was quantified to assess the impact of antioxidants.

Main Results:

  • Antioxidant agents significantly reduced the frequency of D-SSB (18.3% to 68.2% reduction) at high ADR concentrations.
  • PA-SSB formation remained unaffected by the presence of antioxidant agents.
  • Free radical-mediated DNA damage (D-SSB) was observed only at very high ADR concentrations, exceeding clinically achievable levels.

Conclusions:

  • ADR-induced D-SSB in euoxic cells is mediated by free radicals, but only at supra-therapeutic concentrations.
  • At clinically relevant ADR concentrations, DNA damage likely occurs via a non-free radical mechanism, predominantly involving PA-SSB.

Related Concept Videos